SEC Form 4 · accession 0001179110-15-001181
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Gregory Almstead
Officer — EVP, Research and CMC
Period of report
Jan 20, 2015
Accepted (ET)
Jan 22, 2015 · 9:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 20, 2015 | M | 5,000 | $10.85 | A | 34,881 | D | |
| Common Stock | Jan 20, 2015 | M | 20,100 | $10.85 | A | 54,981 | D | |
| Common StockF2 | Jan 20, 2015 | S | 24,600 | $60.25 | D | 30,381 | D | |
| Common StockF3 | Jan 20, 2015 | S | 500 | $61.02 | D | 29,881 | D | |
| Common Stock | Jan 21, 2015 | M | 996 | $10.85 | A | 30,877 | D | |
| Common Stock | Jan 21, 2015 | S | 996 | $60.00 | D | 29,881 | D | |
| Common Stock | holding | — | — | — | 1,374 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F4 | $10.85 | Jan 20, 2015 | M | 5,000 | A | — | May 15, 2023 | Common Stock | 5,000 | 10,000 | D |
| Stock Option (Right To Buy)F5 | $10.85 | Jan 20, 2015 | M | 20,100 | A | — | May 15, 2023 | Common Stock | 20,100 | 74,900 | D |
| Stock Option (Right To Buy)F5 | $10.85 | Jan 21, 2015 | M | 996 | A | — | May 15, 2023 | Common Stock | 996 | 73,904 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $60.00 to $60.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $61.00 to $61.06 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- F5This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 30, 2014.